Insufficient scRNA-seq data for expression of H2BC12L at single-cell level.
Insufficient scRNA-seq data for expression of H2BC12L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
peripheral blood | 64% | 1.73 | 590 / 929 | 0% | 0 | 0 / 0 |
spleen | 45% | 0.72 | 109 / 241 | 0% | 0 | 0 / 0 |
prostate | 42% | 0.67 | 103 / 245 | 0% | 0 | 0 / 0 |
lung | 38% | 0.61 | 219 / 578 | 0% | 0 | 0 / 0 |
ovary | 37% | 0.46 | 66 / 180 | 0% | 0 | 0 / 0 |
thymus | 33% | 0.48 | 218 / 653 | 0% | 0 | 0 / 0 |
skin | 32% | 0.50 | 578 / 1809 | 0% | 0 | 0 / 0 |
adipose | 31% | 0.47 | 376 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 31% | 0.43 | 446 / 1445 | 0% | 0 | 0 / 0 |
liver | 31% | 0.54 | 69 / 226 | 0% | 0 | 0 / 0 |
blood vessel | 30% | 0.45 | 407 / 1335 | 0% | 0 | 0 / 0 |
uterus | 29% | 0.38 | 49 / 170 | 0% | 0 | 0 / 0 |
intestine | 29% | 0.41 | 278 / 966 | 0% | 0 | 0 / 0 |
adrenal gland | 27% | 0.37 | 69 / 258 | 0% | 0 | 0 / 0 |
breast | 26% | 0.37 | 119 / 459 | 0% | 0 | 0 / 0 |
stomach | 24% | 0.32 | 86 / 359 | 0% | 0 | 0 / 0 |
bladder | 24% | 0.43 | 5 / 21 | 0% | 0 | 0 / 0 |
pancreas | 23% | 0.34 | 77 / 328 | 0% | 0 | 0 / 0 |
heart | 18% | 0.22 | 158 / 861 | 0% | 0 | 0 / 0 |
brain | 16% | 0.20 | 433 / 2642 | 0% | 0 | 0 / 0 |
muscle | 14% | 0.16 | 112 / 803 | 0% | 0 | 0 / 0 |
kidney | 8% | 0.09 | 7 / 89 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0002227 | Biological process | innate immune response in mucosa |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0021762 | Biological process | substantia nigra development |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0005615 | Cellular component | extracellular space |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000786 | Cellular component | nucleosome |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003677 | Molecular function | DNA binding |
GO_0030527 | Molecular function | structural constituent of chromatin |
Gene name | H2BC12L |
Protein name | Histone H2B type F-S (H2B-clustered histone 12 like) (H2B.S histone 1) (Histone H2B.s) (H2B/s) |
Synonyms | H2BFS H2BS1 |
Description | FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; FUNCTION: Has broad antibacterial activity. May contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid. |
Accessions | P57053 ENST00000599962.2 |